Ascendis Pharma A/S (ASND)
USD 155.5
(2.99%)
USD 155.5
(2.99%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 644.26 Million EUR | 26.73% |
| 2022 | 508.37 Million EUR | 384.35% |
| 2021 | 104.96 Million EUR | 14.12% |
| 2020 | 91.97 Million EUR | 151.17% |
| 2019 | 36.61 Million EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | 0.0% |
| 2015 | - EUR | 0.0% |
| 2014 | - EUR | 0.0% |
| 2013 | - EUR | -100.0% |
| 2012 | 212 Thousand EUR | -47.0% |
| 2011 | 400 Thousand EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 673.03 Million EUR | 0.54% |
| 2024 Q1 | 669.01 Million EUR | 3.84% |
| 2023 Q3 | 665.84 Million EUR | 31.61% |
| 2023 Q4 | 644.26 Million EUR | -3.24% |
| 2023 FY | 644.26 Million EUR | 26.73% |
| 2023 Q1 | 505.38 Million EUR | -0.59% |
| 2023 Q2 | 505.93 Million EUR | 0.11% |
| 2022 FY | 508.37 Million EUR | 384.35% |
| 2022 Q4 | 508.37 Million EUR | -8.11% |
| 2022 Q3 | 553.24 Million EUR | 8.01% |
| 2022 Q2 | 512.2 Million EUR | 8.14% |
| 2022 Q1 | 473.66 Million EUR | 351.27% |
| 2021 FY | 104.96 Million EUR | 14.12% |
| 2021 Q2 | 101 Million EUR | 4.69% |
| 2021 Q3 | 102.3 Million EUR | 1.28% |
| 2021 Q4 | 104.96 Million EUR | 2.6% |
| 2021 Q1 | 96.48 Million EUR | 4.9% |
| 2020 Q3 | 33.28 Million EUR | -6.2% |
| 2020 Q4 | 91.97 Million EUR | 176.37% |
| 2020 FY | 91.97 Million EUR | 151.17% |
| 2020 Q1 | 37.06 Million EUR | 1.22% |
| 2020 Q2 | 35.48 Million EUR | -4.28% |
| 2019 Q3 | 36.92 Million EUR | 1.72% |
| 2019 FY | 36.61 Million EUR | 0.0% |
| 2019 Q4 | 36.61 Million EUR | -0.83% |
| 2019 Q2 | 36.3 Million EUR | 107.63% |
| 2019 Q1 | 17.48 Million EUR | 0.0% |
| 2018 FY | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2017 Q1 | - EUR | 0.0% |
| 2017 Q4 | - EUR | 0.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| 2017 Q3 | - EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 Q3 | - EUR | 0.0% |
| 2016 Q1 | - EUR | 0.0% |
| 2016 FY | - EUR | 0.0% |
| 2016 Q4 | - EUR | 0.0% |
| 2015 Q1 | - EUR | 0.0% |
| 2015 Q4 | - EUR | 0.0% |
| 2015 Q3 | - EUR | 0.0% |
| 2015 Q2 | - EUR | 0.0% |
| 2015 FY | - EUR | 0.0% |
| 2014 Q2 | - EUR | 0.0% |
| 2014 Q3 | - EUR | 0.0% |
| 2014 Q4 | - EUR | 0.0% |
| 2014 FY | - EUR | 0.0% |
| 2014 Q1 | - EUR | 0.0% |
| 2013 Q1 | - EUR | 0.0% |
| 2013 Q4 | - EUR | 0.0% |
| 2013 FY | - EUR | -100.0% |
| 2012 FY | 212 Thousand EUR | -47.0% |
| 2011 FY | 400 Thousand EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agenus Inc. | 350.24 Million USD | -83.946% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -4360.433% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -2244.06% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -449.747% |
| MiMedx Group, Inc. | 48.09 Million USD | -1239.456% |
| Novavax, Inc. | 280.63 Million USD | -129.574% |
| Seer, Inc. | 28.25 Million USD | -2179.858% |
| Acelyrin, Inc. | 1.19 Million USD | -53858.543% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -181.104% |
| IO Biotech, Inc. | 2.49 Million USD | -25732.598% |
| Ardelyx, Inc. | 55.98 Million USD | -1050.843% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -807.722% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -2984.935% |
| Fortress Biotech, Inc. | 88.59 Million USD | -627.227% |
| Fortress Biotech, Inc. | 88.59 Million USD | -627.227% |
| Geron Corporation | 85.89 Million USD | -650.026% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -459.399% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -9722.61% |
| Incyte Corporation | 38.28 Million USD | -1582.725% |
| Innoviva, Inc. | 449.07 Million USD | -43.465% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -19560.208% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -10350.365% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| NextCure, Inc. | 6.6 Million USD | -9654.201% |
| Onconetix, Inc. | 9.88 Million USD | -6417.093% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -202499.057% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -79596.117% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -22332.625% |
| Vaxcyte, Inc. | 29.22 Million USD | -2104.575% |
| Precigen, Inc. | 7.09 Million USD | -8977.991% |
| Pharming Group N.V. | 171.54 Million USD | -275.566% |
| ContextLogic Inc. | 6 Million USD | -10637.75% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -66456.302% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -2920.323% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -963.512% |
| AlloVir, Inc. | 27.42 Million USD | -2248.846% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -483.795% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -222334.169% |
| Summit Therapeutics Inc. | 106.09 Million USD | -507.23% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -39304.587% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -10277.98% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1610.468% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -535.47% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -844.255% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -8313.629% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1712.01% |
| Chimerix, Inc. | 2.14 Million USD | -29949.674% |
| PDS Biotechnology Corporation | 23.85 Million USD | -2601.138% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -3728.075% |
| CRISPR Therapeutics AG | 238.63 Million USD | -169.983% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1905.931% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -363.4% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -2157.332% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1960.461% |
| Dyadic International, Inc. | 136.92 Thousand USD | -470410.264% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2037.787% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -11710.541% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -518.403% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 75.984% |
| Aptorum Group Limited | 3.36 Million USD | -19060.884% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1333.101% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -637786.139% |
| Clearside Biomedical, Inc. | 43 Million USD | -1398.256% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -103479.082% |
| GT Biopharma, Inc. | 58 Thousand USD | -1110701.724% |
| Alkermes plc | 290.73 Million USD | -121.603% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -1315.656% |
| Jaguar Health, Inc. | 35.86 Million USD | -1696.612% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -30289.858% |
| AbCellera Biologics Inc. | 77.38 Million USD | -732.599% |
| PureTech Health plc | 25.51 Million USD | -2425.341% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -142888.563% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1590.807% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -71010.927% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -4865.051% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -9072.338% |
| AnaptysBio, Inc. | 17.81 Million USD | -3516.622% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -3213.268% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -801942.874% |
| Molecular Templates, Inc. | 12.23 Million USD | -5167.907% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -378.993% |
| Vaxxinity, Inc. | 15.16 Million USD | -4147.528% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -2420.993% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -38875.499% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -2525.153% |
| Structure Therapeutics Inc. | 5.45 Million USD | -11714.87% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -135534.737% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -9325.969% |
| ImmuCell Corporation | 11.96 Million USD | -5282.644% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -274673.853% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -300958.411% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Opthea Limited | 200.62 Million USD | -221.123% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -6439.434% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -937.882% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -522.262% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -206.587% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -18012.595% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -38089.982% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -214145.097% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -2472.738% |
| Aptose Biosciences Inc. | 1 Million USD | -63700.869% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -7442887.523% |
| Soligenix, Inc. | 3.49 Million USD | -18336.221% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1237.454% |
| Kura Oncology, Inc. | 17.2 Million USD | -3645.727% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -597.008% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -407662.658% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -29865.814% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -4510.455% |
| Autolus Therapeutics plc | 52.96 Million USD | -1116.352% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -11680.307% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1439.72% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -180.809% |
| GRI Bio, Inc. | 14 Thousand USD | -4601792.857% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -5085.649% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1490.542% |
| INmune Bio, Inc. | 10.43 Million USD | -6072.895% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -258.666% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -10806.697% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -788667.14% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -77818.567% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1144.355% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -1005.446% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -1013.259% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -33.987% |
| Verastem, Inc. | 41.55 Million USD | -1450.316% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -11830.833% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -5565.362% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -6465.423% |
| Histogen Inc. | 4.62 Million USD | -13839.096% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -18966.736% |
| Organovo Holdings, Inc. | 1.39 Million USD | -46117.001% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -1300.524% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -12304.024% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -2933.406% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -3017534.66% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -661.651% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -308131.27% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -2032.198% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -396817.76% |
| Apollomics, Inc. | 4.66 Million USD | -13722.463% |
| Amarin Corporation plc | 8.73 Million USD | -7273.984% |
| Mesoblast Limited | 118.92 Million USD | -441.75% |
| Turnstone Biologics Corp. | 3.21 Million USD | -19945.582% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -660.877% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -260736.032% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -560.06% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -239.187% |
| Better Therapeutics, Inc. | 14.88 Million USD | -4229.738% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -2004.478% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -480.796% |
| NLS Pharmaceutics AG | 1.63 Million USD | -39334.833% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -10410.033% |
| Gritstone bio, Inc. | 104.77 Million USD | -514.903% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -23025.09% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1318224.125% |
| Avid Bioservices, Inc. | 207.83 Million USD | -209.99% |
| Insmed Incorporated | 1.2 Billion USD | 46.489% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -9500.134% |
| OmniAb, Inc. | 25.56 Million USD | -2420.5% |
| Alector, Inc. | 38.91 Million USD | -1555.442% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -201.148% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -4152.294% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -34.661% |
| Aura Biosciences, Inc. | 19.55 Million USD | -3194.294% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -919.939% |
| Immunic, Inc. | 1.33 Million USD | -48195.727% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1930.332% |
| Veracyte, Inc. | 12.63 Million USD | -5001.069% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 0.093% |
| FibroGen, Inc. | 170.45 Million USD | -277.968% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -6994.648% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -315854.019% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 88.886% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1741156.757% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -15105.688% |
| TG Therapeutics, Inc. | 110.79 Million USD | -481.493% |
| Galecto, Inc. | 249 Thousand USD | -258640.964% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -38571.369% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 61.605% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -8705.043% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -11837.465% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -23025.09% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -2296.73% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1329.381% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -45302.748% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1324.231% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1392.425% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1235.846% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 24.089% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -62608.415% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -5781.013% |
| NexImmune, Inc. | 68.8 Thousand USD | -936209.204% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -4538895.35% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 76.164% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -164252.478% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -9229.062% |
| Ainos, Inc. | 5.96 Million USD | -10703.37% |
| Pluri Inc. | 29.61 Million USD | -2075.689% |
| Prothena Corporation plc | 11.83 Million USD | -5343.726% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -2453.061% |
| Celularity Inc. | 65.41 Million USD | -884.859% |
| Rallybio Corporation | 392 Thousand USD | -164253.316% |
| Cue Biopharma, Inc. | 14.69 Million USD | -4284.246% |
| MeiraGTx Holdings plc | 89.26 Million USD | -621.752% |
| Omeros Corporation | 338.28 Million USD | -90.453% |
| Humacyte, Inc. | 58.1 Million USD | -1008.775% |
| Immunocore Holdings plc | 84.03 Million USD | -666.69% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -34668.753% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -13110.273% |
| Blueprint Medicines Corporation | 774.12 Million USD | 16.775% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -12739.079% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -942.196% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -518.914% |
| Pulmatrix, Inc. | 8.75 Million USD | -7257.983% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -9214.226% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -4551.733% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -458.55% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1942.173% |
| Cytokinetics, Incorporated | 755.77 Million USD | 14.754% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -4713.695% |
| Nutriband Inc. | 241.28 Thousand USD | -266914.112% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -11684.617% |
| Vor Biopharma Inc. | 35.66 Million USD | -1706.688% |
| Roivant Sciences Ltd. | 499.74 Million USD | -28.918% |
| Evogene Ltd. | 1.13 Million USD | -56513.796% |
| ProKidney Corp. | 4.41 Million USD | -14499.252% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -52450.163% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1167787.247% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 62.97% |
| CorMedix Inc. | 667.63 Thousand USD | -96400.018% |
| BioLineRx Ltd. | 11.59 Million USD | -5458.321% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1555.357% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -797.218% |
| Atai Life Sciences N.V. | 16.47 Million USD | -3810.324% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -26185.845% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -95346.667% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -1307.522% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -991076.923% |
| MediciNova, Inc. | 215.92 Thousand USD | -298273.054% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -25722.244% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -50990.46% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -245.688% |
| Biomea Fusion, Inc. | 10.29 Million USD | -6157.43% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -55.235% |
| Mereo BioPharma Group plc | 5.95 Million USD | -10724.345% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -17846.1% |
| Absci Corporation | 15.95 Million USD | -3937.507% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -6932.693% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -4291.418% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -2250.046% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -5155.874% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -5051.647% |
| Allakos Inc. | 41.46 Million USD | -1453.756% |
| Imunon, Inc. | 1.62 Million USD | -39554.056% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -5853.84% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -426565.563% |
| BioAtla, Inc. | 2.46 Million USD | -26089.634% |
| NLS Pharmaceutics AG | 1.63 Million USD | -39334.833% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -570046.018% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -577.311% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -11516.751% |
| XOMA Corporation | 124.45 Million USD | -417.69% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -3302.868% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1392.494% |
| aTyr Pharma, Inc. | 15.09 Million USD | -4168.069% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -5684.387% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -2373.851% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -2960.932% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -184503.152% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -197228.886% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -39383.675% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 57.027% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -392823.576% |
| UroGen Pharma Ltd. | 100.21 Million USD | -542.889% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -252.541% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -185919.888% |
| Orgenesis Inc. | 22.62 Million USD | -2748.084% |
| Entera Bio Ltd. | 390 Thousand USD | -165096.154% |
| GH Research PLC | 343 Thousand USD | -187732.362% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -211134.426% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -66114.286% |
| Xencor, Inc. | 83.43 Million USD | -672.185% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -373012.762% |
| Replimune Group, Inc. | 75.86 Million USD | -749.181% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -52526.312% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -6750.968% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -392823.576% |
| Portage Biotech Inc. | 47 Thousand USD | -1370676.596% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -50990.46% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -26555.565% |
| OncoCyte Corporation | 2.86 Million USD | -22356.082% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -49488.752% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -427829.514% |
| Purple Biotech Ltd. | 351 Thousand USD | -183451.282% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -20294.587% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1499.903% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -1158.502% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -453607.746% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -12216.288% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -2309.548% |
| Curis, Inc. | 2.79 Million USD | -22958.876% |
| Daré Bioscience, Inc. | 5.31 Million USD | -12014.468% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -30055.88% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -113929.204% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -3750.726% |
| BeiGene, Ltd. | 930.18 Million USD | 30.738% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -4045.183% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -632.586% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -56364.943% |
| Erasca, Inc. | 55.85 Million USD | -1053.377% |
| bluebird bio, Inc. | 330.32 Million USD | -95.039% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 43.18% |
| DBV Technologies S.A. | 14.38 Million USD | -4379.974% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -25650.0% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -13773.062% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -59.163% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -1299.39% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -13878.412% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -25244.807% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -3317.308% |
| MacroGenics, Inc. | 33.97 Million USD | -1796.515% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -2979.072% |
| Prime Medicine, Inc. | 13.63 Million USD | -4625.776% |
| Aditxt, Inc. | 18.21 Million USD | -3436.423% |
| Adagene Inc. | 22.3 Million USD | -2788.191% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -4110.057% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -5.45% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -3074.814% |
| SciSparc Ltd. | 76 Thousand USD | -847617.105% |
| Vericel Corporation | 88.14 Million USD | -630.932% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -685.528% |
| Generation Bio Co. | 97.89 Million USD | -558.125% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -195725.228% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -2446.703% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -212.878% |
| Invivyd, Inc. | 2.16 Million USD | -29658.199% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1104.999% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -18283508.563% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -11523.038% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -1022542.857% |
| 2seventy bio, Inc. | 256.67 Million USD | -151.006% |
| ADMA Biologics, Inc. | 141.41 Million USD | -355.575% |
| Clene Inc. | 32.16 Million USD | -1903.249% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -11379.817% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -29251.481% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1171.442% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -133774.638% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -233.484% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -2038.568% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -3646.38% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -417.316% |
| Evaxion Biotech A/S | 10.86 Million USD | -5827.176% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -672.602% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -760.087% |
| Trevena, Inc. | 35.23 Million USD | -1728.584% |
| Surrozen, Inc. | 3.37 Million USD | -18966.736% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -9817.873% |
| Cingulate Inc. | 3.13 Million USD | -20450.069% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1571278.049% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -2287.051% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -128520.711% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -106743.284% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -1026.239% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -138451.613% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -2178.809% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -3086.434% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -41331.833% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -51032.143% |
| Statera Biopharma, Inc. | 16.26 Million USD | -3861.992% |
| ImmunityBio, Inc. | 883.67 Million USD | 27.093% |
| Korro Bio, Inc. | 33.2 Million USD | -1840.148% |
| Kineta, Inc. | 1.31 Million USD | -48819.134% |
| BioVie Inc. | 6.11 Million USD | -10441.939% |
| Codexis, Inc. | 22.36 Million USD | -2780.813% |
| Celularity Inc. | 65.41 Million USD | -884.859% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1145.486% |
| Celcuity Inc. | 37.44 Million USD | -1620.505% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -287133.616% |
| Cibus, Inc. | 24.62 Million USD | -2516.73% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -168115.405% |
| IN8bio, Inc. | 4.89 Million USD | -13067.075% |
| Kodiak Sciences Inc. | 181.63 Million USD | -254.709% |
| Annexon, Inc. | 31.35 Million USD | -1954.744% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -758.608% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -27409.18% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -16406.918% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 55.676% |
| Eyenovia, Inc. | 16.1 Million USD | -3899.718% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -477.868% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -65307.614% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -5523.331% |
| Arcellx, Inc. | 97.62 Million USD | -559.939% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -29879.758% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -2329.997% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -20669.342% |
| Moolec Science SA | 2.64 Million USD | -24255.184% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -2161.611% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -10105.37% |
| Royalty Pharma plc | 6.13 Billion USD | 89.499% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -26722.023% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -558895.783% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1804.419% |
| Humacyte, Inc. | 58.1 Million USD | -1008.775% |
| 89bio, Inc. | 27.1 Million USD | -2276.66% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -4749.202% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -25476.221% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -48051.345% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -507.43% |
| Notable Labs, Ltd. | 2.04 Million USD | -31342.899% |
| Liquidia Corporation | 3.5 Million USD | -18291.807% |
| Mustang Bio, Inc. | 2.49 Million USD | -25691.233% |
| Immunovant, Inc. | 138 Thousand USD | -466758.696% |
| Quantum-Si incorporated | 15.3 Million USD | -4110.057% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -7287.513% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -160966.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1099.57% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -788667.14% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -5809.062% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -305980.128% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -317271.921% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -3018.266% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -159767.246% |
| PepGen Inc. | 20.1 Million USD | -3104.661% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -112141.289% |
| United Therapeutics Corporation | 700 Million USD | 7.962% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -2352.941% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -14335.826% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -72616.14% |
| XOMA Corporation | 124.45 Million USD | -417.69% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -235033.212% |
| Bionomics Limited | 239.61 Million USD | -168.872% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -31574.794% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -4752.855% |
| uniQure N.V. | 138.4 Million USD | -365.479% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -654.206% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -62328.779% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -65307.614% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -6994.648% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -36778.363% |
| Altimmune, Inc. | 671 Thousand USD | -95915.648% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -44.759% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -4752.855% |
| Compugen Ltd. | 1.35 Million USD | -47588.009% |
| Peak Bio, Inc. | 10.72 Million USD | -5908.922% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1406.489% |
| Benitec Biopharma Inc. | 284 Thousand USD | -226753.873% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -661.948% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -3134.1% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -5369.607% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -604.438% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -3134.1% |
| Instil Bio, Inc. | 86.05 Million USD | -648.675% |
| argenx SE | 20 Million USD | -3121.325% |
| Immunome, Inc. | 1.65 Million USD | -38946.364% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -37076.284% |
| Verona Pharma plc | 51.32 Million USD | -1155.168% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -6488.924% |
| Shattuck Labs, Inc. | 4.2 Million USD | -15232.342% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -177873.757% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -15309.352% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -110030.769% |
| Moolec Science SA | 2.64 Million USD | -24255.184% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -2032.675% |
| Design Therapeutics, Inc. | 3.05 Million USD | -21023.443% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -245802.672% |
| NeurAxis, Inc. | 224.26 Thousand USD | -287184.848% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -4428.149% |
| Lumos Pharma, Inc. | 6.58 Million USD | -9683.827% |
| Achilles Therapeutics plc | 4.61 Million USD | -13860.238% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -6488.924% |
| 180 Life Sciences Corp. | 1.32 Million USD | -48705.403% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -3672.016% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -41331.833% |
| Nutriband Inc. | 241.28 Thousand USD | -266914.112% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -6208.284% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -77898.184% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -72.392% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -2040.486% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -17322.616% |
| Palisade Bio, Inc. | 369 Thousand USD | -174497.561% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -155144.578% |
| Beam Therapeutics Inc. | 173.17 Million USD | -272.035% |
| Neurogene Inc. | 16.25 Million USD | -3863.488% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -109.081% |
| AEON Biopharma, Inc. | 278 Thousand USD | -231650.0% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -192217.91% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -602630.819% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -749.259% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -954.323% |
| Athira Pharma, Inc. | 1.58 Million USD | -40547.634% |
| Vaccinex, Inc. | 247 Thousand USD | -260736.032% |
| HCW Biologics Inc. | 6.45 Million USD | -9885.854% |
| XOMA Corporation | 124.45 Million USD | -417.69% |
| Nektar Therapeutics | 230.4 Million USD | -179.628% |
| Arvinas, Inc. | 3.4 Million USD | -18848.971% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -39383.675% |
| Merus N.V. | 12.16 Million USD | -5197.361% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -401.655% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -4563.856% |
| Rezolute, Inc. | 2.22 Million USD | -28816.741% |
| Clene Inc. | 32.16 Million USD | -1903.249% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -367939.965% |
| BeyondSpring Inc. | 3.99 Million USD | -16026.783% |
| Synlogic, Inc. | 17.27 Million USD | -3629.465% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -49458.846% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1840657.143% |
| Peak Bio, Inc. | 10.72 Million USD | -5908.922% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1140.809% |
| Krystal Biotech, Inc. | 8.09 Million USD | -7859.786% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -263.959% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -9029.446% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -471564.202% |
| MannKind Corporation | 382.37 Million USD | -68.489% |
| Ikena Oncology, Inc. | 10.73 Million USD | -5899.86% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -157422.005% |
| Gossamer Bio, Inc. | 212.46 Million USD | -203.235% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -370167.241% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -6932.693% |
| Legend Biotech Corporation | 328.67 Million USD | -96.021% |
| Mural Oncology plc | 15 Million USD | -4192.524% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -1258.464% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -30564.683% |
| Champions Oncology, Inc. | 7.43 Million USD | -8571.131% |
| REGENXBIO Inc. | 89.29 Million USD | -621.542% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -75279.345% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -116407.409% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -11799.982% |
| Vaxart, Inc. | 26.51 Million USD | -2329.905% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -4014.774% |
| Cellectis S.A. | 92.85 Million USD | -593.855% |
| Longeveron Inc. | 2.04 Million USD | -31466.144% |
| Repare Therapeutics Inc. | 3.41 Million USD | -18793.402% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 53.876% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -1282.78% |
| Revolution Medicines, Inc. | 87.94 Million USD | -632.586% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -372307.514% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -16198.128% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -203138.17% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -368051.429% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 20.304% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1133.255% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -4372.366% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -46789.738% |
| Cingulate Inc. | 3.13 Million USD | -20450.069% |
| Passage Bio, Inc. | 26.29 Million USD | -2350.236% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -9566.392% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -157808.088% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -71965.436% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -3033.432% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -51032.143% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -26184.504% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -20529.683% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -79340.814% |
| OmniAb, Inc. | 25.56 Million USD | -2420.5% |
| Anew Medical, Inc. | 1.6 Million USD | -40041.121% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -2077.832% |
| Lipocine Inc. | 17.16 Thousand USD | -3753045.753% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -5435.874% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1760.532% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -10806.697% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -1026.869% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -317271.921% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -12373.669% |
| Ocugen, Inc. | 6.94 Million USD | -9182.02% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4459.877% |
| Q32 Bio Inc. | 1.31 Million USD | -48782.018% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -95772.768% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1877.486% |
| Equillium, Inc. | 824 Thousand USD | -78087.5% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -6996.211% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -214079.571% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -323.026% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -1159.856% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -83025.819% |
| Dominari Holdings Inc. | 3.02 Million USD | -21176.915% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -681755.705% |
| vTv Therapeutics Inc. | 529 Thousand USD | -121689.225% |
| Bio-Techne Corporation | 419.53 Million USD | -53.565% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -794.862% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -232.84% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -3714.928% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -2730.441% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -10534.946% |
| Nkarta, Inc. | 88.33 Million USD | -629.31% |
| BioCardia, Inc. | 1.31 Million USD | -48893.536% |
| Iterum Therapeutics plc | 19.5 Million USD | -3202.399% |